Novo Nordisk has ended its partnership with Hims & Hers Health after two months, accusing the telehealth company of pushing ...

Novo Nordisk unveiled its latest data for a weight-loss drug candidate, but shares of the maker of Wegovy and Ozempic tumbled ...

Hims & Hers Health Inc.’s stock fell sharply on Monday after pharmaceutical giant Novo Nordisk, maker of the weight-loss drug ...

From today, June 23, GPs can prescribe Mounjaro, a weight loss injection, to certain patients on the NHS. The drug, also ...

And promoting these drugs, in the absence of a comprehensive plan to tackle the underlying causes of obesity, will not ...

Novo Nordisk ends partnership with Hims & Hers over safety and marketing concerns tied to compounded Wegovy, as rivalry with ...

These resources will help you to learn more about Oviva, and how their Tier 3 Weight Management programme helps eligible patients achieve their weight loss goals. Oviva’s Tier 3 Weight Management ...

Prescriptions for Mounjaro jabs, an effective weight loss pill, are now accessible at general practitioners' surgeries in ...

Eli Lilly & Co.'s experimental weight loss pill helped patients shed pounds without serious side effects in a clinical trial, ...

GLP-1 therapies primarily use single-use injectable pens, contributing to medical waste challenges. The pharmaceutical ...

How do weight loss drugs like Ozempic and Mounjaro work? Administered as weekly jabs, these drugs – often called GLP-1 ...

Plus, we take an in-depth look at another possible weight loss solution for patients who’ve tried other methods and failed.